Sweat tattoos: UMass Amherst develops skin-friendly monitors for health insights

University of Massachusetts Amherst researchers have received an award to develop a new type of sweat monitor that can be applied to the skin just like a temporary tattoo and assess the molecules present, such as cortisol.

Europe lines up first CRISPR therapy approval

Following FDA approval, Vertex Pharmaceuticals and CRISPR Therapeutics on Friday received a positive recommendation for a conditional approval by a key European medicines panel for

December 16, 2023

$750,000 training program grant awarded to support the Industrial Hygiene Program

The National Institute for Occupational Safety and Health, a division of the National Institutes of Health, awarded a $750,000 training program grant to researchers at

August 17, 2023

Curaleaf Q1 Revenue Growth Stalls

First quarter 2024 revenue of $339 million, representing an increase of 2% year-over-year and adjusted gross margin(1) of 48% First quarter 2024 adjusted EBITDA(1) of

May 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.